GRAND RAPIDS, Mich. — There's exciting news when it comes to preventing breast cancer. The FDA just approved a breast cancer vaccine for testing in humans.
High-risk breast cancer patients will be the first to be admitted into the trials but there are a few more details that need to be ironed out before the vaccine trial is widely open to all who qualify.
The vaccine targets certain proteins produced by a patient's own body.
Dr. Paul Wright, a surgical oncologist with Spectrum Health, talks with 13 ON YOUR SIDE Health Reporter Val Lego about this advancement.
►Make it easy to keep up to date with more stories like this. Download the 13 ON YOUR SIDE app now.